VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to show that valsartan compared to atenolol has favorable effects
on exercise capacity, quality of life, diastolic function and elevated blood pressure in
hypertensive postmenopausal overweight women with impaired exercise tolerance despite normal
left ventricular ejection fraction (LVEF).